Valsartan and Losartan Recalls

Patients taking angiotensin receptor blockers (ARBs) like valsartan and Losartan rely on the drugs prescribed to them for safe, healthy lives, and when the drugs stop being safe, the consequences can be devastating. For example, due to the unexpected presence of the contaminants N-nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) in certain batches of valsartan and Losartan manufactured in China and India, patients taking the hypertension medication could be at risk for stomach cancer, colorectal cancer, kidney cancer, liver damage, tumors and liver cancer. If you believe you have been adversely affected by side effects of the blood pressure medication valsartan or losartan, please complete the online form on this page or call now. You may have grounds to file a valsartan or losartan lawsuit against the companies found at fault for the NDMA and NDEA contamination, in order to pursue financial compensation for your injuries, medical expenses, pain and suffering, and other losses.

Valsartan Recall Lawsuit | Consumer Safety Watch

History of Valsartan/Losartan Recalls

Several pharmaceutical companies have voluntarily recalled their medications containing valsartan and losartan after it was discovered that the drug may have been tainted with the carcinogen NDMA or NDEA during the manufacturing process. According to reports, certain batches of valsartan manufactured by both Zhejiang Huahai Pharmaceuticals in China and Hetero Labs Limited in India may have become tainted by NDMA. Formerly used in the production of liquid rocket fuel, softeners for copolymers and additives for lubricants, the Environmental Protection Agency (EPA) reports that NDMA is now only produced in pure form for research purposes. The safety of drugs imported from other countries has long been disputed, and the FDA has announced that it will continue to investigate the levels of NDMA contamination in the recalled valsartan products to determine how to eliminate the impurity from future batches of the drug. Says Dr. Harry Lever, a cardiologist at the Cleveland Clinic in Ohio, “It’s not just valsartan. It’s becoming very difficult for me to write prescriptions at all. There are so many drugs that are coming in from India and China and companies are buying and selling each other and you don’t know what’s what.”

Side Effects of Valsartan

  • Stomach Cancer
  • Gastric Cancer
  • Liver cancer
  • Liver damage
  • Tumors of the liver, kidneys, respiratory tract and blood vessels
  • Headaches
  • Enlarged liver
  • Dizziness

  • Colorectal Cancer
  • Kidney Cancer
  • Abdominal cramps
  • Jaundice
  • Nausea and vomiting
  • Fever
  • Reduced function of the liver, lungs and kidneys

By lowering blood pressure, sartan drugs can reduce the risk of heart attacks and strokes, but when it contains an impurity like NDMA or NDEA, it can put patients at seriously increased risk for liver cancer, kidney cancer, stomach/gastric cancer, colorectal cancer,  liver damage and other serious side effects.

What are Valsartan and Losartan?

Valsartan, the generic version of the brand-name drug Diovan, is a medication commonly used to treat high blood pressure (hypertension) and heart failure. It can also be used to lower the risk of death after a heart attack. Valsartan is an angiotensin-II receptor antagonist and it works by blocking a substance in the body that causes blood vessels to constrict, thereby lowering blood pressure and allowing an increased supply of oxygen to reach the heart. High blood pressure is a common condition affecting one in four American adults, but few people realize that prolonged hypertension can result in potentially life-threatening medical problems. If high blood pressure continues for a long period of time, the heart and arteries may not be able to function properly, and this can damage blood vessels in the heart, brain and kidneys, possibly resulting in heart failure, stroke or kidney failure. By lowering blood pressure, valsartan can reduce the risk of heart attacks and strokes, but when it contains an impurity like NDMA, it can put patients at risk for liver damage and other serious side effects.

Why File a Valsartan Lawsuit?

Patients taking recalled valsartan medications contaminated with NDMA may be able to seek financial compensation for:

  • Liver damage, cancer and other physical injuries
  • Stomach or gastric cancer
  • Colorectal Cancer
  • Kidney Cancer
  • Pancreatic Cancer
  • Bladder Cancer
  • Past and future medical expenses to treat your injuries
  • Lost wages
  • Loss of future earning capacity
  • Emotional pain and suffering
  • Economic losses resulting from your injuries
  • Punitive damages, if appropriate

Valsartan Lawsuit Information

Valsartan lawsuits allege that the blood pressure medication can be contaminated with a substance called N-nitrosodimethylamine (NDMA), which is classified as a probable human carcinogen, meaning exposure to it can cause cancer. In May 2018, the European Medicines Agency began reviewing valsartan-containing medications supplied by the Chinese company Zhejiang Huahai Pharmaceuticals, after NMDA was detected in the valsartan it was supplying to manufacturers in the European Union. In July 2018, the FDA announced that three companies were voluntarily recalling their valsartan medications supplied by Zhejiang Huahai Pharmaceuticals, after detecting the presence of NDMA in the medications. It is believed that the NDMA contamination in question could have begun as early as 2012, when Zhejiang Huahai Pharmaceuticals changed its manufacturing process.

In August 2018, the FDA announced a recall of certain batches of valsartan produced by India-based company Hetero Labs Limited, due to the presence of NDMA, and Torrent Pharmaceuticals also announced the recall of 14 lots of Valsartan/Amlodipine/HCTZ tablets due to NDMA contamination. The FDA action came after 22 other countries recalled 2,300 batches of valsartan supplied to Germany, Finland, Sweden, Norway, Ireland, Hungary, the Netherlands, Austria, Bulgaria, Spain, Belgium, Bosnia, Canada, Greece, Poland, Croatia, Italy, Portugal, France, Lithuania, and Herzegovina, Bahrain and Malta. In the aftermath of the valsartan recall, attorneys across the country are investigating claims on behalf of patients who suffered serious health consequences as a result of taking valsartan contaminated by NDMA.

Get Your Free Case Evaluation

Our case evaluations are free, confidential, and carry no obligation. Call us or fill out the form on this page to get started.
866-391-4464 Fill Out Form
Rate This Service